Multifunctional Magnetic Resonance Imaging in Predicting Breast Lesions in Women Undergoing Mastectomy for Breast Cancer
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00602316 |
Recruitment Status : Unknown
Verified June 2009 by National Cancer Institute (NCI).
Recruitment status was: Recruiting
First Posted : January 28, 2008
Last Update Posted : August 26, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
RATIONALE: Diagnostic procedures, such as multifunctional magnetic resonance imaging, may help doctors learn the extent of disease and plan the best treatment.
PURPOSE: This clinical trial is studying how well multifunctional magnetic resonance imaging works in predicting breast lesions in women undergoing mastectomy for breast cancer.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Breast Cancer | Drug: gadolinium-chelate Procedure: conventional surgery Procedure: magnetic resonance imaging Procedure: magnetic resonance spectroscopic imaging | Not Applicable |
OBJECTIVES:
- To determine the accuracy of multifunctional magnetic resonance (MR) in detecting, localizing, and characterizing satellite lesions in relation to an index breast tumor in order to improve definition of clinical target volume after local excision.
OUTLINE: Patients receive an injection of gadolinium chelate and undergo multifunctional magnetic resonance (MR) imaging, including dynamic contrast-enhanced MR, hydrogen-MR spectroscopy, and diffusion-weighted MRI, of the ipsilateral breast within 4 weeks before surgery. Patients undergo a mastectomy as planned. The resected specimen is photographed, and a histopathological analysis is performed consisting of the size and grade (if pre-invasive or invasive disease) of each satellite lesion, classification of benign satellite lesions, dimensions of each lesion, distance from the edge of the index tumor to the center of each satellite lesion, and the distance from the center of the surface of the nipple to the center of each lesion.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 20 participants |
Primary Purpose: | Diagnostic |
Official Title: | Using Magnetic Resonance Techniques to Improve the Characterisation and Localisation of Breast Cancer. A Pilot Observational Study Testing the Accuracy of Multifunctional Magnetic Resonance Techniques in Predicting the Presence, Distribution and Nature of Breast Lesions in Women With Known Breast Cancer |
Study Start Date : | November 2007 |
Estimated Primary Completion Date : | September 2009 |

- Sensitivity of magnetic resonance (MR) techniques in detecting histopathologically-identified multifocal and multicentric lesions
- Closeness of agreement between MR techniques and histopathology in localizing satellite lesions relative to the index tumor
- Assessment of distribution of satellite lesions in relation to index tumor
- Correlation between histopathological characteristics and signal changes on multifunctional MR

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
- Biopsy-confirmed invasive ductal carcinoma of the breast
- Unifocal disease as defined by clinical examination, mammography, and ultrasound
- Patient must be proceeding to mastectomy
- Hormone receptor status unknown
- No T4d or multifocal disease (as defined on conventional imaging)
- Index tumor ≤ 4 cm in diameter
PATIENT CHARACTERISTICS:
- Menopausal status not specified
- Female
- No claustrophobia
- No cup size of DD or greater
PRIOR CONCURRENT THERAPY:
- No prior surgery to ipsilateral breast
- No prior neoadjuvant chemotherapy
- No prior ferromagnetic implants

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00602316
United Kingdom | |
Royal Marsden - Surrey | Recruiting |
Sutton, England, United Kingdom, SM2 5PT | |
Contact: Contact Person 44-208-661-3392 annakirby@doctors.org.uk |
OverallOfficial: | Anna Kirby | Royal Marsden NHS Foundation Trust |
ClinicalTrials.gov Identifier: | NCT00602316 |
Other Study ID Numbers: |
CDR0000581176 RMH-CCR2995 |
First Posted: | January 28, 2008 Key Record Dates |
Last Update Posted: | August 26, 2013 |
Last Verified: | June 2009 |
invasive ductal breast carcinoma stage IA breast cancer stage IB breast cancer stage II breast cancer stage IIIA breast cancer |
Breast Neoplasms Neoplasms by Site Neoplasms Breast Diseases |
Skin Diseases Chelating Agents Sequestering Agents Molecular Mechanisms of Pharmacological Action |